The Cyprus Institute of Neurology & Genetics: New “RESTART 2016–2020, Bilateral Collaborations” Programme EDIT-4-IRON: Genome Editing for Iron-Restrictive Therapy of Hereditary and Acquired Haematological Disorders
The Molecular Genetics Thalassemia Department (MGTD) of the Cyprus Institute of Neurology & Genetics (CING) proudly announces the start of a new project named EDIT-4-IRON: Genome Editing for Iron-Restrictive Therapy of Hereditary and Acquired Haematological Disorders. This 36-month project is funded with €200,000.00 under the “RESTART 2016–2020, Bilateral Collaborations” programme of The Research and Innovation Foundation. EDIT-4-IRON is a bilateral Cyprus-Israel programme that …